Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Oncology Reviews is Scopus-indexed (Q2, CiteScore 5), WoS ESCI, DOAJ. Published by Frontiers Media SA.
Checked against the index lists dated .
ISSN 1970-5557Verify ISSN ↗1970-5565Verify ISSN ↗
Publisher: Frontiers Media SA
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 155 / 428 | 63rd | Q2 |
| Cancer Research | 124 / 233 | 46th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2007–present, best quartile Q2, CiteScore 5.
Oncology Reviews is Q2 in Oncology (rank 155 of 428) and Q3 in Cancer Research (rank 124 of 233), by CiteScore 2025.
Oncology Reviews is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5, which places it in quartile Q2 at the 63rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.096, quartile Q2, with an H-index of 35.
The publisher lists an article processing charge of about US$2,353 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Oncology Reviews is published by Frontiers Media SA. Its print ISSN is 1970-5557 and its online ISSN is 1970-5565.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Oncology Reviews has an h-index of 42 and a 2-year mean of 4.69 citations per paper (OpenAlex). Its Scopus CiteScore is 5, quartile Q2. On 2-year citations it ranks #63 of 424 Scopus journals in Oncology.
Oncology Reviews published 50 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2025–2026), authors are most often from China (33.8%), Italy (13.3%) and United States (12.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (4.7 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.